Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NK Cells for AML Consolidation in Children
NCT02763475Phase 2Completed
- Sponsor
- Hospital La Paz Institute for Health Research
- Start
- May 2016
- Primary completion
- Aug 2020
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of autologous activated and expanded natural killer cells in acute myeloid leukemia (AML), sponsored by Hospital La Paz Institute for Health Research. Started May 2016; status: completed.
02
Drugs
autologous activated and expanded natural killer cells
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02763475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02763475.